Annual Long Term Debt
$365.21 M
-$1.46 M-0.40%
December 31, 2023
Summary
- As of February 10, 2025, CERE annual long term debt is $365.21 million, with the most recent change of -$1.46 million (-0.40%) on December 31, 2023.
- During the last 3 years, CERE annual long term debt has risen by +$334.24 million (+1079.28%).
Performance
CERE Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Debt
$364.79 M
-$424.00 K-0.12%
March 31, 2024
Summary
- As of February 10, 2025, CERE quarterly long term debt is $364.79 million, with the most recent change of -$424.00 thousand (-0.12%) on March 31, 2024.
- Over the past year, CERE quarterly long term debt has dropped by -$820.00 thousand (-0.22%).
Performance
CERE Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
CERE Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.4% | -0.2% |
| 3 y3 years | +1079.3% | +991.9% |
| 5 y5 years | +1314.5% | +991.9% |
CERE Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.4% | -90.7% | -0.6% | -91.0% |
| 5 y | 5-year | -0.4% | -92.9% | -0.6% | -91.5% |
| alltime | all time | -0.4% | -92.9% | -0.6% | -91.5% |
Cerevel Therapeutics Holdings Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $364.79 M(-0.1%) |
| Dec 2023 | $365.21 M(-0.4%) | $365.21 M(-0.1%) |
| Sep 2023 | - | $365.61 M(-0.1%) |
| Jun 2023 | - | $365.98 M(-0.1%) |
| Mar 2023 | - | $366.34 M(-0.1%) |
| Dec 2022 | $366.67 M | $366.67 M(-0.1%) |
| Sep 2022 | - | $366.95 M(+1022.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $32.69 M(-2.2%) |
| Mar 2022 | - | $33.41 M(-2.1%) |
| Dec 2021 | $34.11 M(+10.1%) | $34.11 M(-1.8%) |
| Sep 2021 | - | $34.75 M(+5.6%) |
| Jun 2021 | - | $32.91 M(-0.1%) |
| Mar 2021 | - | $32.95 M(+6.4%) |
| Dec 2020 | $30.97 M(+19.9%) | $30.97 M |
| Dec 2019 | $25.82 M | - |
FAQ
- What is Cerevel Therapeutics Holdings annual long term debt?
- What is the all time high annual long term debt for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings annual long term debt year-on-year change?
- What is Cerevel Therapeutics Holdings quarterly long term debt?
- What is the all time high quarterly long term debt for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings quarterly long term debt year-on-year change?
What is Cerevel Therapeutics Holdings annual long term debt?
The current annual long term debt of CERE is $365.21 M
What is the all time high annual long term debt for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high annual long term debt is $366.67 M
What is Cerevel Therapeutics Holdings annual long term debt year-on-year change?
Over the past year, CERE annual long term debt has changed by -$1.46 M (-0.40%)
What is Cerevel Therapeutics Holdings quarterly long term debt?
The current quarterly long term debt of CERE is $364.79 M
What is the all time high quarterly long term debt for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high quarterly long term debt is $366.95 M
What is Cerevel Therapeutics Holdings quarterly long term debt year-on-year change?
Over the past year, CERE quarterly long term debt has changed by -$820.00 K (-0.22%)